This is the first post in our mini-series on valuation myths in venture capital . We’ll explore some of the most common shortcuts used in reporting and why they don’t align with global standards like the International Private Equity and Venture Capital Valuation (IPEV) Guidelines and ASC 820 (Fair Value Measurement under US GAAP). Let’s start with one of the most persistent misconceptions: using cost as a proxy for fair value. In venture capital, valuation is more than a tech